Cardiac cath team gets a new member. Defining a new sub-specialty: interventional echocardiography

Structural heart procedures are growing, and so is the cath lab team.

For two straight years, Diagnostic and Interventional Cardiology (DAIC) magazine has reported from the American Society of Echocardiography (ASE) Annual Scientific Sessions on the rise of a new sub-specialty—interventional echocardiography.

Interventional echocardiography crucial to structural heart

Structural heart procedures have seen rapid growth in the cath lab—and have been a featured topic at many of our 2016 regional educational conferences—and for all but the most expert interventionalists, echocardiography plays a big role in those cases.

Continue reading Cardiac cath team gets a new member. Defining a new sub-specialty: interventional echocardiography

“Absorb” Approved; Bioresorbable, Drug-coated Stent to Roll Out “in a Phased Way”

Yesterday, the Food and Drug Administration approved Abbott’s Absorb stent, the first fully dissolving stent to be approved by the FDA.

A 10-person FDA advisory panel, including Dr. George Vetrovec of Virginia Commonwealth University, voted unanimously in March to affirm that the stent’s benefits and efficacy outweigh its risks. The same panel voted 9-1 in favor of its safety profile, despite the risk of blood clots for some patients.

“This is presumably a better technology going forward – at least that’s the theory – but it will take years to prove,” said Vetrovec to the Associated Press.

FDA approves Absorb with advisory panel warning

Continue reading “Absorb” Approved; Bioresorbable, Drug-coated Stent to Roll Out “in a Phased Way”